Advanced Biomed Inc. (NASDAQ:ADVB) Sees Significant Drop in Short Interest

Advanced Biomed Inc. (NASDAQ:ADVB) was the target of a significant drop in short interest during the month of May. As of May 15th, there was short interest totaling 3,722 shares, a drop of 72.3% from the April 30th total of 13,424 shares. Based on an average daily volume of 522,925 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.4% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of Advanced Biomed from a “sell (d)” rating to a “sell (d-)” rating in a research report on Tuesday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

Advanced Biomed Stock Up 28.1%

Advanced Biomed stock opened at $5.01 on Friday. The business has a 50-day moving average price of $5.05. The company has a market cap of $6.91 million, a price-to-earnings ratio of 1.04 and a beta of 0.56. Advanced Biomed has a 12-month low of $3.61 and a 12-month high of $24.00.

Advanced Biomed (NASDAQ:ADVB) last released its earnings results on Friday, May 15th. The company reported ($0.38) earnings per share (EPS) for the quarter.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.